首页> 中文期刊> 《中国全科医学》 >乳酸菌片联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻疗效观察

乳酸菌片联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻疗效观察

摘要

目的 观察乳酸菌片联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻的临床疗效.方法 178例肺炎继发性腹泻患儿按月龄分为两组:1~18个月龄(Ⅰ组)和19~36个月龄(Ⅱ组),Ⅰ、Ⅱ组再随机分为治疗组和对照组.对照组在常规治疗的基础上口服乳酸菌片,治疗组在常规治疗的基础上服用乳酸菌片和复方胃蛋白酶散.结果 Ⅰ组和Ⅱ组中治疗组和对照组的治疗效果比较,差异均有统计学意义(u值分别为2.288和2.0796,P<0.05);总有效率Ⅰ组中治疗组明显高于对照组,差异有统计学意义(P<0.05),但在Ⅱ组中治疗组和对照组总有效率间差异无统计学意义(P>0.05).服药期间两组均未出现不良反应.结论 乳酸菌片联合复方胃蛋白酶散两者优势互补,具有口感好、患儿和家属易接受、疗效好、安全及无不良反应等优点,尤其在1~18个月小儿效果显著,值得推广.%Objective To investigate the clinical efficacy of Lactic acid pepsin tablets combined with Compound Powder in the treatment of diarrhea in children with pneumonia. Methods 178 cases of diarrhea in children with pneumonia were divided into two groups by age : 1 to 18 months ( group Ⅰ ) and 19 to 36 months ( group Ⅱ ). Group Ⅰ and group Ⅱ were randomly divided into treatment group and control group. Besides the conventional treatment, the control group was given oral lactobacillus tablets, while the treatment group was given lactic acid bacteria pepsin tablets and powder compound. Results The difference of efficacy between the treatment group and control group in group Ⅰ and group Ⅱ were statistically significant ( the value were 2. 288 and 2. 0796, P <0. 05 ). The overall efficiency of treatment group was significantly higher than that of control group in group Ⅰ ( P <0. 05 ). While no significant difference of overall efficiency was found between the treatment group and control group in group Ⅱ ( P > 0. 05 ). No adverse effects were found during treatment. Conclusion Lactic Acid Pepsin Tablets combined with Compound Powder has advantages like good taste, good efficacy, and safe without adverse effect. The complementary two medicines are specifically effective among babies aged between 1 to 18 months and should be promoted.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号